Anxo Pharmaceutical Co., Ltd. (TPEX:6677)
Taiwan · Delayed Price · Currency is TWD 20.10
+0.75 (3.88%)
Mar 26, 2026, 1:07 PM CST
Anxo Pharmaceutical Market Cap
Anxo Pharmaceutical has a market cap or net worth of 1.11 billion as of March 26, 2026. Its market cap has decreased by -20.72% in one year.
Market Cap
1.11B
Enterprise Value
1.63B
Revenue
883.22M
Ranking
n/a
PE Ratio
n/a
Stock Price
20.10
Market Cap Chart
Since June 27, 2018, Anxo Pharmaceutical's market cap has decreased from 2.16B to 1.11B, a decrease of -48.73%. That is a compound annual growth rate of -8.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 1.08B | 3.20% |
| Dec 31, 2025 | 1.05B | -21.58% |
| Dec 31, 2024 | 1.34B | -50.67% |
| Dec 29, 2023 | 2.71B | 89.95% |
| Dec 30, 2022 | 1.43B | 20.33% |
| Dec 30, 2021 | 1.18B | -13.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tien Liang BioTech | 1.62B |
| GeneFerm Biotechnology | 1.56B |
| InnoPharmax | 1.55B |
| Winston Medical Supply | 1.30B |
| DV Biomed | 1.29B |
| Excelsior Biopharma | 1.23B |
| Mediera | 1.03B |
| Original BioMedicals | 1.02B |